JP2024546578A5 - - Google Patents
Info
- Publication number
- JP2024546578A5 JP2024546578A5 JP2024528581A JP2024528581A JP2024546578A5 JP 2024546578 A5 JP2024546578 A5 JP 2024546578A5 JP 2024528581 A JP2024528581 A JP 2024528581A JP 2024528581 A JP2024528581 A JP 2024528581A JP 2024546578 A5 JP2024546578 A5 JP 2024546578A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- hsgsh
- raav
- mirna target
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163278775P | 2021-11-12 | 2021-11-12 | |
| US63/278,775 | 2021-11-12 | ||
| US202163288293P | 2021-12-10 | 2021-12-10 | |
| US63/288,293 | 2021-12-10 | ||
| PCT/US2022/079701 WO2023086928A2 (en) | 2021-11-12 | 2022-11-11 | Gene therapy for treatment of mucopolysaccharidosis iiia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546578A JP2024546578A (ja) | 2024-12-26 |
| JP2024546578A5 true JP2024546578A5 (cg-RX-API-DMAC7.html) | 2025-11-18 |
Family
ID=86336670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024528581A Pending JP2024546578A (ja) | 2021-11-12 | 2022-11-11 | ムコ多糖症iiia型の治療のための遺伝子療法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250041445A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4430201A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024546578A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240133693A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022388800A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3237987A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2024007283A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL312676A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024005735A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023086928A2 (cg-RX-API-DMAC7.html) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019013528A (es) * | 2017-05-12 | 2020-07-14 | The Children´S Hospital Of Philadelphia | Variantes de sulfamidasa (sgsh) y vectores, composiciones, metodos y usos para tratar la mucopolisacaridosis tipo iiia (mps iiia). |
| US11555206B2 (en) * | 2017-11-30 | 2023-01-17 | The Trustees Of The University Of Pennsylvania | Gene therapy for mucopolysaccharidosis IIIA |
| JP7577650B2 (ja) * | 2018-10-10 | 2024-11-05 | アミカス セラピューティックス インコーポレイテッド | ジスルフィド結合により安定したポリペプチド組成物及びその使用方法 |
| BR112021009913A2 (pt) * | 2018-12-05 | 2021-08-17 | Abeona Therapeutics, Inc. | vetor viral adeno-associado recombinante para inserção gênica |
| MX2021007600A (es) * | 2018-12-21 | 2021-08-11 | Univ Pennsylvania | Composiciones para la reduccion de la expresion transgenica especifica de drg. |
| US20220193261A1 (en) * | 2019-04-30 | 2022-06-23 | The Trustees Of The University Of Pennsylvania | Compositions useful for treatment of pompe disease |
-
2022
- 2022-11-11 AU AU2022388800A patent/AU2022388800A1/en active Pending
- 2022-11-11 KR KR1020247019262A patent/KR20240133693A/ko active Pending
- 2022-11-11 US US18/709,415 patent/US20250041445A1/en active Pending
- 2022-11-11 IL IL312676A patent/IL312676A/en unknown
- 2022-11-11 JP JP2024528581A patent/JP2024546578A/ja active Pending
- 2022-11-11 EP EP22893867.6A patent/EP4430201A4/en active Pending
- 2022-11-11 WO PCT/US2022/079701 patent/WO2023086928A2/en not_active Ceased
- 2022-11-11 CA CA3237987A patent/CA3237987A1/en active Pending
-
2024
- 2024-05-09 MX MX2024005735A patent/MX2024005735A/es unknown
- 2024-06-11 CO CONC2024/0007283A patent/CO2024007283A2/es unknown